CD4 and precursor B-cell acute lymphoblastic leukemia: Conversely, the double-positive CD3 subset (CD3+CD4+CD8+ T cells) was significantly reduced in B-ALL patients compared to controls (0.94% vs. 1.61%, p < 0.0001), highlighting a notable alteration in T-cell distribution in B-ALL.